| Therapeutics Acquisition is a newly organized blank check company incorporated in Delaware and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. Co.'s primary focus is on acquiring a business focusing on the healthcare industry, with an emphasis on the biotechnology sector. We show 4 historical shares outstanding datapoints in our RACA shares outstanding history coverage, used to compute RACA market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing RACA market cap history over the course of time is important for investors
interested in comparing RACA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of RACA versus a peer is one thing; comparing
RACA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like RACA can fluctuate over the course of history.
With this page we aim to empower investors researching RACA by allowing them to research the RACA market cap history.